Ono Pharmaceutical Co., Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of OPHLY for the last quarter is 759.50 M USD, and it's 14.38% lower compared to the previous quarter. The net income of Q4 23 is 117.42 M USD.